StemCell Institute Inc. (TYO:7096)
Japan
· Delayed Price · Currency is JPY 1,281.00
-24.00 (-1.84%)
May 12, 2025, 3:30 PM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 13.37 billion as of May 12, 2025. Its market cap has decreased by -28.88% in one year.
Market Cap
13.37B
Enterprise Value
10.24B
Revenue
2.64B
Ranking
n/a
PE Ratio
33.85
Stock Price
1,281.00
Market Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 13.37B, a decrease of -36.80%. That is a compound annual growth rate of -11.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 13.37B | 1.24% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 13.53T |
| Takeda Pharmaceutical Company | 6,661.64B |
| Daiichi Sankyo Company | 6,621.02B |
| HOYA Corporation | 6,073.43B |
| Terumo | 4,094.38B |
| Otsuka Holdings | 3,746.75B |
| Astellas Pharma | 2,520.47B |
| Olympus | 2,230.71B |